Inhibikase Therapeutics, Inc.IKTNASDAQ
LOADING
|||
Switch Symbol:
Operating Income Growth Under Pressure
Trending lower.
Left:
||||
Year-over-year operating income growth rate
Latest
-22.42%
Near historical average
Average (30q)
-24.91%
Historical baseline
Range
High:64.95%
Low:-309.73%
Volatility
-1504.2%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -22.42% |
| Q2 2025 | 25.80% |
| Q1 2025 | -12.91% |
| Q4 2024 | -121.86% |
| Q3 2024 | -15.38% |
| Q2 2024 | -5.61% |
| Q1 2024 | -8.60% |
| Q4 2023 | 7.66% |
| Q3 2023 | 23.11% |
| Q2 2023 | -31.55% |
| Q1 2023 | -8.77% |
| Q4 2022 | 3.95% |
| Q3 2022 | 2.73% |
| Q2 2022 | 0.01% |
| Q1 2022 | 7.95% |
| Q4 2021 | -12.76% |
| Q3 2021 | -70.11% |
| Q2 2021 | -0.12% |
| Q1 2021 | -118.62% |
| Q4 2020 | -80.93% |
| Q3 2020 | -60.35% |
| Q2 2020 | 23.35% |
| Q1 2020 | -27.89% |
| Q4 2019 | 64.95% |
| Q3 2019 | 48.49% |
| Q2 2019 | -34.97% |
| Q1 2019 | -37.61% |
| Q4 2018 | 0.00% |
| Q1 2018 | -309.73% |
| Q4 2017 | 0.00% |
| Q1 2017 | 0.00% |